- Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute
Kei Sonehara et al, 2019, Chemotherapy CrossRef - Diagnostic Test Accuracy of Glasgow Prognostic Score as a Prognostic Factor for Renal Cell Carcinoma
Sun Il Kim et al, 2020, American Journal of Clinical Oncology CrossRef - Lactate Dehydrogenase-to-Lymphocyte Ratio Represents a Powerful Prognostic Tool of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
Tao Li et al, 2020, Pathology & Oncology Research CrossRef - Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro‐tumourigenicity
John Davies et al, 2022, Pigment Cell & Melanoma Research CrossRef - A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
Tongyu Tong et al, 2020, Frontiers in Oncology CrossRef - C-reactive protein to albumin ratio predicts the outcome in renal cell carcinoma: A meta-analysis
Wei Zhou et al, 2019, PLOS ONE CrossRef - Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy
Go Kaneko et al, 2019, Japanese Journal of Clinical Oncology CrossRef - Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre
Mark Stares et al, 2023, Cancer Medicine CrossRef - Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients
Takashi Matsuki et al, 2020, Cancer Medicine CrossRef - Identification of vital prognostic genes related to tumor microenvironment in pheochromocytoma and paraganglioma based on weighted gene co-expression network analysis
Chun-Xian Chen et al, 2021, Aging CrossRef - Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis
Yuan Shao et al, 2020, BMC Urology CrossRef - Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patients
Kazuki Abe et al, 2022, European Journal of Clinical Pharmacology CrossRef